-
News
Alnylam Shares Sink 30% After Q2 Miss, Guidance Cut
Alnylam Pharmaceuticals lost nearly a third of its market value Wednesday after the RNAi drugmaker’s second-quarter numbers came in behind…
Alnylam Pharmaceuticals lost nearly a third of its market value Wednesday after the RNAi drugmaker’s second-quarter numbers came in behind…